Importance of Protein Binding for the Interpretation of Serum or Plasma Drug Concentrations
Open Access
- 6 May 1982
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 22 (5-6) , 259-263
- https://doi.org/10.1002/j.1552-4604.1982.tb02671.x
Abstract
The extent of drug binding to plasma protein does not influence the concentration of unbound drug in plasma at steady state but does influence the interpretation of total drug concentrations. An increase in free fraction (reduction in the extent of binding) decreases the therapeutic and toxic ranges for total drug concentrations. Conversely, a reduction in free fraction (increase in the extent of binding) increases these ranges. Laboratories generally measure total rather than unbound drug concentrations, and clinicians must use caution in interpreting these total drug concentrations in clinical situations where the extent of binding of extensively bound drugs may be altered. Free drug serum or plasma concentrations are inherently more reliable indices of the intensity of drug action than are total concentrations. Methodology for routine measurement of free concentration is becoming available and should ultimately be utilized for therapeutic monitoring of drugs that are highly bound to protein.This publication has 19 references indexed in Scilit:
- Entry of diazepam and its major metabolite into cerebrospinal fluidPsychopharmacology, 1980
- Disease-induced Changes in the Plasma Binding of Basic DrugsClinical Pharmacokinetics, 1980
- Pharmacokinetic and Clinical Implications of Quinidine Protein BindingJournal of Pharmaceutical Sciences, 1979
- Diseases and Drug Protein BindingClinical Pharmacokinetics, 1978
- The Binding of Drugs to Plasma Proteins from Patients with Poor Renal FunctionClinical Pharmacokinetics, 1976
- Binding of Drugs to Serum AlbuminNew England Journal of Medicine, 1976
- Plasma and Tissue Protein Binding of Drugs in PharmacokineticsDrug Metabolism Reviews, 1976
- Clinical PharmacokineticsNew England Journal of Medicine, 1975
- Pharmacokinetics of drugs in patients with the nephrotic syndrome.Journal of Clinical Investigation, 1975
- Potentiation of Warfarin-Induced Hypoprothrombinemia by Chloral HydrateNew England Journal of Medicine, 1970